Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults.
NCT00714285
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
420
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
GSK Biologicals' quadrivalent influenza vaccine
BIOLOGICAL:
GSK Biologicals' trivalent influenza vaccine
Sponsor
GlaxoSmithKline